Immediate Impact
61 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
Works of Kisha Mitchell-Richards being referenced
Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination
2017
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kisha Mitchell-Richards | 36 | 19 | 65 | 124 | 104 | 13 | 331 | |
| Ya-Ju Du | 10 | 7 | 43 | 123 | 109 | 13 | 359 | |
| Kozue Uchio | 31 | 31 | 72 | 145 | 53 | 12 | 343 | |
| Sung‐Su Yun | 28 | 3 | 91 | 69 | 130 | 16 | 310 | |
| K Umeshita | 39 | 25 | 116 | 87 | 107 | 17 | 353 | |
| Kenji Fukumoto | 9 | 3 | 41 | 99 | 45 | 17 | 273 | |
| Cristina Bárcena | 19 | 9 | 85 | 141 | 78 | 9 | 369 | |
| Greg Cohen | 50 | 56 | 39 | 175 | 73 | 10 | 364 | |
| Zhiming Huang | 14 | 20 | 23 | 139 | 59 | 13 | 343 | |
| P Ross | 13 | 8 | 73 | 115 | 89 | 12 | 356 | |
| Yang Liu | 8 | 12 | 55 | 164 | 66 | 11 | 366 |
All Works
Loading papers...